<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">ARYA Atheroscler</journal-id><journal-id journal-id-type="iso-abbrev">ARYA Atheroscler</journal-id><journal-id journal-id-type="publisher-id">ARYA</journal-id><journal-title-group><journal-title>ARYA Atherosclerosis</journal-title></journal-title-group><issn pub-type="ppub">1735-3955</issn><issn pub-type="epub">2251-6638</issn><publisher><publisher-name>Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24575140</article-id><article-id pub-id-type="pmc">3933054</article-id><article-id pub-id-type="publisher-id">ARYA-09-363</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison of effects of soft margarine, blended, ghee, and unhydrogenated oil with hydrogenated oil on serum lipids: A randomized clinical trail</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mohammadifard</surname><given-names>Noushin</given-names></name><xref ref-type="aff" rid="af1-ARYA-09-363">1</xref><xref rid="c1-ARYA-09-363" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Hosseini</surname><given-names>Mohsen</given-names></name><xref ref-type="aff" rid="af2-ARYA-09-363">2</xref></contrib><contrib contrib-type="author"><name><surname>Sajjadi</surname><given-names>Firoozeh</given-names></name><xref ref-type="aff" rid="af3-ARYA-09-363">3</xref></contrib><contrib contrib-type="author"><name><surname>Maghroun</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="af4-ARYA-09-363">4</xref></contrib><contrib contrib-type="author"><name><surname>Boshtam</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="af1-ARYA-09-363">1</xref></contrib><contrib contrib-type="author"><name><surname>Nouri</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="af1-ARYA-09-363">1</xref></contrib></contrib-group><aff id="af1-ARYA-09-363"><label>1</label>Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="af2-ARYA-09-363"><label>2</label>Associate Professor, Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="af3-ARYA-09-363"><label>3</label>Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="af4-ARYA-09-363"><label>4</label>Hypertension Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran</aff><author-notes><corresp id="c1-ARYA-09-363">Correspondence to: Noushin Mohammadifard, Email: <email xlink:href="mohammadifard@crc.mui.ac.ir">mohammadifard@crc.mui.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2013</year></pub-date><volume>9</volume><issue>6</issue><fpage>363</fpage><lpage>371</lpage><history><date date-type="received"><day>06</day><month>9</month><year>2013</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2013 Isfahan Cardiovascular Research Center &#x00026; Isfahan University of Medical Sciences</copyright-statement><copyright-year>2013</copyright-year><license xlink:href="http://creativecommons.org/licenses/by-nc/3.0/" license-type="open-access"><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p></license></permissions><abstract><sec id="st1"><title>BACKGROUND</title><p>Trans fatty acids (TFAs) are known as the most harmful type of dietary fats. Therefore, this study was done to compare the effects of some different oils including unhydrogenated, blended, ghee, and soft magazine with hydrogenated oil on serum lipid profile of healthy adults.</p></sec><sec id="st2"><title>METHODS</title><p>This study was a randomized clinical trial conducted on 206 healthy participants of 20 to 60 years of age. Subjects were randomly divided into 5 groups and each of them was treated with a diet containing unhydrogenated oil, ghee, blended oil, soft margarine, or hydrogenated oil for 40 days. Fasting serum lipids were measured before and after the study. </p></sec><sec id="st3"><title>RESULTS</title><p>Compared to hydrogenated oil, total cholesterol (TC) and triglyceride (TG) had a significant reduction in all groups, LDL-C declined in unhydrogenated oil and soft margarine groups, and apolipoprotein (Apo) B only in unhydrogenated oil group (all P &#x0003c; 0.05). However, there was a significant enhancement in ApoA of ghee oil (P &#x0003c; 0.001).</p></sec><sec id="st4"><title>CONCLUSION</title><p>Consuming unhydrogenated oil, ghee, soft margarine, and blended oil had some beneficial effects on serum lipids.</p></sec></abstract><kwd-group><kwd>Clinical Trial</kwd><kwd>Dietary Fat</kwd><kwd>Commercial Oil</kwd><kwd>Lipid</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Diets affect the occurrence, progress, and prevention of non-communicable diseases, including cardiovascular diseases (CVD), cancers, diabetes, and hypertension.<xref rid="b1-ARYA-09-363" ref-type="bibr">1</xref>,<xref rid="b2-ARYA-09-363" ref-type="bibr">2</xref> In the last few decades, the reduction of fat intake has been the major recommendation for decreasing CVD risk.<xref rid="b3-ARYA-09-363" ref-type="bibr">3</xref> There is a great amount of evidence confirming that the type of dietary fat is more determinant in CVD development than its amount.<xref rid="b4-ARYA-09-363" ref-type="bibr">4</xref> Saturated fatty acids (SFAs) cause an increase in serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels.<xref rid="b5-ARYA-09-363" ref-type="bibr">5</xref></p><p>In the past, the effects of fats on increasing plasma TC levels were estimated by their saturation degree.<xref rid="b4-ARYA-09-363" ref-type="bibr">4</xref>,<xref rid="b6-ARYA-09-363" ref-type="bibr">6</xref> However, the evidence obtained during this past decade indicates that the trans fatty acid (TFA) existing in hydrogenated oils not only increases LDL-C, TC, and apolipoprotein (Apo) B levels, but also decreases high-density lipoprotein cholesterol (HDL-C) and ApoA levels.<xref rid="b7-ARYA-09-363" ref-type="bibr">7</xref> Therefore, TFAs are more harmful than SFAs.<xref rid="b8-ARYA-09-363" ref-type="bibr">8</xref> Scientists at the Public Health School of Harvard University estimated that in the US in 2001, about 30,000 people died of CVD events caused by TFAs.<xref rid="b9-ARYA-09-363" ref-type="bibr">9</xref> It was reported that the mean TFA content of hydrogenated oils produced in Iran was 34.6 &#x000b1; 6.6% (Range: 22.5-46.2%), which is much higher than the World Health Organization recommendation.<xref rid="b10-ARYA-09-363" ref-type="bibr">10</xref>,<xref rid="b11-ARYA-09-363" ref-type="bibr">11</xref></p><p>Thus, now TFA substitutions are needed to preserve the originality of and offer an appealing many packed food textures. Blending is one alternative method to partial hydrogenation for modifying the physical and functional characteristics of edible fats and oils.<xref rid="b12-ARYA-09-363" ref-type="bibr">12</xref> This process can provide nutritional needs with improved oxidative stability for domestic cooking and deep-frying, while, unlike partial hydrogenation, it will not produce TFAs with low content of saturated fatty acids.<xref rid="b13-ARYA-09-363" ref-type="bibr">13</xref></p><p>Furthermore, ghee is produced from milk by traditional methods and usually called "yellow oil" or "Kermanshahi oil" in Iran. Although it is produced from animal fat and contains high amounts of SFAs and cholesterol, a few studies reported it was useful for decreasing LDL-C and increasing HDL-C.<xref rid="b14-ARYA-09-363" ref-type="bibr">14</xref>-<xref rid="b16-ARYA-09-363" ref-type="bibr">16</xref> In an animal study which was conducted in Iran, it has been observed that ghee oil consumption significantly increased HDL-C level, but did not have any significant effect on other serum lipids.<xref rid="b17-ARYA-09-363" ref-type="bibr">17</xref> However, there is no precise scientific information on this issue in human subjects. Thus, there are some controversies about how ghee consumption and serum lipid profile are linked.<xref rid="b18-ARYA-09-363" ref-type="bibr">18</xref>,<xref rid="b19-ARYA-09-363" ref-type="bibr">19</xref> As TFAs are considered as the most harmful dietary fats, this study was conducted aiming to compare the effects of soft margarine, unhydrogenated, blended, and ghee oils with hydrogenated oil as a main source of TFA on serum lipids of Iranian adults.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><p>
<bold>Study design and sampling</bold>
</p><p>This randomized clinical trial has been conducted on 249 healthy subjects aged 20-60 years in 2009. They were chosen from the Emam-Zaman Beneficiary Organization and consumed only hydrogenated oil in their diet. Normotensive, non-diabetic participants without cardiovascular diseases were invited to the study center. According to the sample size which was calculated 40 in each group and considering the dropout rate, at the beginning we invited 265 volunteers. After overnight fasting, venous blood samples were drawn at 7:00 to 10:00 am. Subjects with TC &#x02265; 240 mg/dl, triglyceride (TG) &#x02265; 400 mg/dl, LDL-C &#x02265; 160 mg/dl, or HDL-C &#x02264; 40 mg/dl, who also had body mass index (BMI) &#x02265; 35 were excluded. However, 16 subjects were excluded because of not meeting the inclusion criteria. Then, the remaining participants were divided into five groups of soft margarine, hydrogenated, unhydrogenated, ghee, and blended oils by simple randomization. Moreover, 43 participants were excluded from the study due to traveling, sickness, unwillingness to participate in the next sampling, or not complying with dietary recommendations. Therefore, 206 healthy subjects were included in the study. The flow chart of the study is presented in <xref ref-type="fig" rid="f1-ARYA-09-363">figure 1</xref>.</p><p>After signing informed written consents, the subjects were referred to the trained nutritionist to obtain socio-demographic characteristics, past medical history, and food habits by 24-hour recall questionnaire. Anthropometrical measurements were taken with shoes removed and the participants wearing light clothing. BMI was calculated by dividing the weight in kilograms to the square of height in meters. Eligible subjects who consumed hydrogenated oil, based on obtained food habits, were randomly divided into 5 groups. They took a diet consultation with the same amount of oil containing soft margarine, cooking and frying unhydrogenated oil, ghee, and blended or hydrogenated oils for 40 days.<xref rid="b20-ARYA-09-363" ref-type="bibr">20</xref> In order to keep the type of oils similar among each group, oils were given to the subjects (every 10 days) by the project conductor. Ghee was provided from Bakhtiari nomads. Soft margarine and blended oil were provided from companies which were their only producers in Iran at that time. The commonest brands of unhydrogenated and hydrogenated oils were bought from the supermarket. Dietary recommendations were given to the subjects by the same dietitian, so that the only difference among the 5 groups was the kind of dietary oil. Oils were provided for all family members, about 20-30 gr per person, even if one of them was chosen in the study. Subjects were followed by phone every two weeks or during their referral to the study center for taking their oil.</p><p>
<bold>Biochemical measurements</bold>
</p><p>Blood samples were taken after the subject had been fasting for 14 hours. Serum lipid levels, including TC, TG, and HDL-C levels, were measured. TC and TG were determined by standard enzymatic method using special kits in Hitachi 902 autoanalyzer and using special kits (Diasys Diagnosis Inc., Holzheim, Germany) performed by Pars-Azmun (Tehran, Iran). HDL-C was measured enzymatically after precipitating the other lipoproteins with dextran sulphate magnesium chloride.<xref rid="b21-ARYA-09-363" ref-type="bibr">21</xref> LDL-C was calculated by using the Friedewald formula. ApoA1 and ApoB100 were assayed by immunoturbidimetric methods (Diasys Diagnosis Inc., Holzheim, Germany) performed by Pars-Azmun. Direct measurement of LDL-C was performed with a turbidimetric method for those with TG &#x02265; 400 mg/dl.<xref rid="b22-ARYA-09-363" ref-type="bibr">22</xref> Apolipoproteins A and B levels were determined by Merk kits. Blood samples were collected before and after the study, at Isfahan Cardiovascular Research Center laboratory, a WHO-collaborating center which meets the criteria of the National Reference Laboratory. The lipid profile changes were the primary endpoint of the study.</p><p>
<bold>Ethics</bold>
</p><p>This study was approved by the Research Council of Isfahan Cardiovascular Research Center and registered in the Iranian Randomized Clinical Trail Center by ID number of IRCT138905124497N1.</p><p>
<bold>Statistical analysis</bold>
</p><p>In the beginning of the study, the mean of age, BMI and serum lipids levels among the three groups were compared by one-way analysis of variance (ANOVA). Comparison of the frequency distribution was conducted using chi-square test based on gender and education level. Mean of serum lipid levels before and after the study were compared by paired t-test in each group. The comparison of changes in serum lipids and ApoA and B levels between 5 groups was done with two-way ANOVA test by adjusting for age, gender, and education level. The post-study mean serum lipid was compared with analysis of co-variances test by adjusting with age, gender, education, and before study serum lipids. P value less than 0.05 was considered significant.</p></sec><sec sec-type="result"><title>Results</title><p>The study was performed on 206 subjects including 41, 43, 39, 42, and 41 subjects in hydrogenated, unhydrogenated, ghee, blended oil, and soft margarine groups, respectively. However, 43 subjects were excluded from the study due to traveling, sickness, unwillingness to participate in the next sampling, or not complying with dietary recommendations. Therefore, 206 healthy subjects were included in the study. Thus, the participation rate was about 82.7%. They included 88 men and 118 women with the mean age of 34.8 &#x000b1; 11.4 years. As shown in <xref ref-type="table" rid="t1-ARYA-09-363">table 1</xref>, there is no significant difference in mean of age, serum lipids, including TC, TG, LDL-C, HDL-C, ApoA, and ApoB levels, and also gender, educational, and marital status distribution between 5 groups in the beginning of the study. <xref ref-type="table" rid="t2-ARYA-09-363">Table 2</xref> demonstrates the comparison between mean of serum lipids and ApoA and ApoB levels before and after the study in each group.</p><p>In the hydrogenated oil group, TC increased and ApoA decreased significantly (P = 0.039 and P = 0.031, respectively). Unhydrogenated oil group had a significant reduction in TC, TG (P &#x0003c; 0.001), and ApoB (P = 0.003) and in the ghee group, ApoA significantly increased (P &#x0003c; 0001). Blended and soft margarine groups had a significant decline in TG (P = 0.010 and P &#x0003c; 0.001, respectively).</p><p>Except for LDL-C, and ApoA and ApoB levels, the comparison of the mean and percentage of serum lipids, changes with age and gender adjustment, revealed a significant difference among the three studied groups (<xref ref-type="fig" rid="f2-ARYA-09-363">Figures 2</xref>-<xref ref-type="fig" rid="f3-ARYA-09-363">3</xref>). TC, TG, and ApoB levels had a significant reduction in the unhydrogenated oil group when compared with the hydrogenated oil group (P &#x0003c; 0.001). In the ghee oil group, TG was significantly decreased, while ApoA had a significant increase (P &#x0003c; 0.001). Comparing with the ghee group, the unhydrogenated oil group had a significant reduction in HDL-C (P &#x0003c; 0.05).</p><p>However TC and TG declined in blended oil and soft margarine groups significantly (P &#x0003c; 0.001 and P &#x0003c; 0.05, respectively).</p><p>The adjusted mean level of serum lipids after the intervention and the mean changes of serum lipids in each intervention group versus hydrogenated oil group are presented in <xref ref-type="table" rid="t3-ARYA-09-363">table 3</xref>. As it shows the soft margarine group had the most significant reduction in TC and TG (&#x003b2; &#x000b1; SE: -8.4 &#x000b1; 2.2; &#x003b2; &#x000b1; SE: -11.2 &#x000b1; 2.5, respectively) (P &#x0003c; 0.001). LDL-C had a significant reduction in unhydrogenated oil and soft margarine (&#x003b2; &#x000b1; SE: -3.8 &#x000b1; 2, P &#x0003c; 0.001; &#x003b2; &#x000b1; SE: -2.5 &#x000b1; 2.3, P &#x0003c; 0.05, respectively). ApoA had a significant increase only in the ghee group and ApoB declined significantly only in the unhydrogenated oil group (&#x003b2; &#x000b1; SE: 3.5 &#x000b1; 2.9, P &#x0003c; 0.001; &#x003b2; &#x000b1; SE: -8.2 &#x000b1; 2.3, P &#x0003c; 0.001, respectively).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>This study indicated that unhydrogenated oil can generally reduce serum lipid levels when compared with hydrogenated oil. However, changes in serum lipids, except for TG reduction and ApoA enhancement, were not significant when the ghee oil group was compared with the hydrogenated oil group (serum HDL-C levels had an insignificant increase). Moreover, blended oil and soft margarine as 2 new products of oil in Iran could reduce TC and TG.</p><p>Several studies have indicated that hydrogenated fat and/or TFAs could increase TC, TG, and LDL-C, decrease HDL-C, and enhance the LDL-C: HDL-C ratio.<xref rid="b16-ARYA-09-363" ref-type="bibr">16</xref>,<xref rid="b23-ARYA-09-363" ref-type="bibr">23</xref>,<xref rid="b24-ARYA-09-363" ref-type="bibr">24</xref> However, the responsible mechanisms for these changes are complicated. It has been proposed that the serum lipid-raising effect of hydrogenated fat is due to either delayed LDL-C clearance or enhanced LDL-C production.<xref rid="b25-ARYA-09-363" ref-type="bibr">25</xref> Matthan et al. have reported that hydrogenated oil decreased HDL-C, and raised LDL-C by increasing ApoA-I and decreased LDL ApoB-100 catabolism. Thus, it was indicated that damaging the cholesterol catabolism is responsible to a greater degree than decreasing its synthesis for the higher serum TC seen by intake of high hydrogenated and saturated fat diets.<xref rid="b26-ARYA-09-363" ref-type="bibr">26</xref> However, Kelley et al. showed that a diet containing cotton seed oil could not modify serum lipids including TC, TG, LDL-C, HDL-C, ApoA and ApoB in comparison with a normal diet.<xref rid="b27-ARYA-09-363" ref-type="bibr">27</xref></p><p>The study by Al-Amoudi and Abu Araki indicated that a blend of the various specific vegetable oils improved serum lipid profiles due to a synergistic effect of various blending oils.<xref rid="b28-ARYA-09-363" ref-type="bibr">28</xref> Enhancement oxidative stability and the synergistic effect of different vegetable oils might cause the serum lipid improvement in the blended oil group of the current study.</p><p>According to the study by Asgary et al. the average TFA contents in hydrogenated oils, and unhydrogenated cooking and frying oils produced in Iran were 35.2 &#x000b1; 4.8%, 0.9 &#x000b1; 0.3%, and 772.6 &#x000b1; 0.8%, respectively.<xref rid="b29-ARYA-09-363" ref-type="bibr">29</xref> Therefore, serum lipid modification by unhydrogenated oils seems reasonable in this study.</p><p>Ghee oil is an important dietary fat used in India and other South Asian countries, which contains high amounts of SFAs (about 59% of its whole fatty acids).<xref rid="b14-ARYA-09-363" ref-type="bibr">14</xref>,<xref rid="b30-ARYA-09-363" ref-type="bibr">30</xref> SFAs, except for stearic acid, increase serum TC.<xref rid="b8-ARYA-09-363" ref-type="bibr">8</xref> Therefore, ghee oil, that is high in cholesterol and SFAs, is considered as harmful. On the other hand, ghee is a good source of oleic acid which is capable of protecting LDL-C particles from oxidation and prevents atherosclerosis.<xref rid="b14-ARYA-09-363" ref-type="bibr">14</xref> Furthermore, according to Asgary et al. the average TFA content in ghee produced by Bakhtiari nomads (the kind of ghee that was used in this study) is 8.3 &#x000b1; 0.7 which is 1.4 times less than the amount of existing TFA in hydrogenated oils.<xref rid="b29-ARYA-09-363" ref-type="bibr">29</xref></p><p>Kumar et al. study indicated that consumption of ghee in the diet, even with high intakes, does not increase serum lipids.<xref rid="b15-ARYA-09-363" ref-type="bibr">15</xref> This animal study did not show any linking between ghee consumption and hypercholesterolemia and hyperlipidemia, which are considered to be risk factors for heart diseases. Interestingly, consuming increased levels of ghee reduced serum TC and TG levels.<xref rid="b15-ARYA-09-363" ref-type="bibr">15</xref> Another idea was that there is a link between the consumption of anhydrous milk fat, such as ghee, and increased risk of heart diseases.<xref rid="b31-ARYA-09-363" ref-type="bibr">31</xref> However, use of excess intake of ghee as a means for lowering serum TC is not recommended, but the study indicates that there is no reason for apprehension for consuming ghee in the diet, which is an age-old practice that is relished in Indian cuisine.<xref rid="b15-ARYA-09-363" ref-type="bibr">15</xref> Mozaffarian et al. stated that substituting 8% of energy intake from TFA with SFA cause a decrease in CVD by modifying TC:HDL-C ratio.<xref rid="b32-ARYA-09-363" ref-type="bibr">32</xref> Therefore, it confirms the suitable effect of ghee on serum lipid profile.</p><p>
<bold>Limitation</bold>
</p><p>As the subjects used the oils for cooking at home, blinding was not applicable. Thus, it was the limitation of this study.</p><sec><title>Conclusion</title><p>Blended and soft margarine as two new kinds of oils in Iran had some beneficial effects on serum lipids. Furthermore, ghee was useful in modifying serum, including TG and HDL-C, and unhydrogenated oil and frying oil consumption resulted in a general reduction in serum lipids. Therefore, it can be said that ghee might be effective on serum lipid modification in metabolic syndrome, but it should not be forgotten that ghee, which is traditionally made from milk fat, has high amounts of SFAs, and also its production method should be carefully supervised.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>We thank the director and personnel of Imam-e-Zaman organization for their kind support in sampling, and also the participants for their patience during follow-up.</p></ack><fn-group><fn><p>
<bold>Conflicts of Interest</bold>
</p><p>Authors have no conflict of interests.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-ARYA-09-363"><label>1</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Koplan</surname><given-names>JP</given-names></name><name><surname>Nugent</surname><given-names>R</given-names></name><name><surname>Dusenbury</surname><given-names>C</given-names></name><name><surname>Puska</surname><given-names>P</given-names></name><name><surname>Gaziano</surname><given-names>TA</given-names></name></person-group>
<source>Prevention of Chronic Disease by Means of Diet and Lifestyle Changes. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al.. Disease Control Priorities in Developing Countries.</source>
<edition>2nd</edition>
<publisher-loc>Washington, DC</publisher-loc>
<publisher-name>World Bank Publications</publisher-name>
<year>2006</year>
<fpage>833</fpage>
<lpage>4</lpage>
</element-citation></ref><ref id="b2-ARYA-09-363"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Flock</surname><given-names>MR</given-names></name><name><surname>Kris-Etherton</surname><given-names>PM</given-names></name></person-group>
<article-title> Dietary Guidelines for Americans 2010: implications for cardiovascular disease.</article-title>
<source>Curr Atheroscler Rep</source>
<year>2011</year>
<volume>13</volume>
<issue>6</issue>
<fpage>499</fpage>
<lpage>507</lpage>
<pub-id pub-id-type="pmid">21874316</pub-id></element-citation></ref><ref id="b3-ARYA-09-363"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kromhout</surname><given-names>D</given-names></name></person-group>
<article-title> Diet and cardiovascular diseases.</article-title>
<source>J Nutr Health Aging</source>
<year>2001</year>
<volume>5</volume>
<issue>3</issue>
<fpage>144</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">11458283</pub-id></element-citation></ref><ref id="b4-ARYA-09-363"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghafoorunissa</surname><given-names>G</given-names></name></person-group>
<article-title> Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.</article-title>
<source>Natl Med J India</source>
<year>2009</year>
<volume>22</volume>
<issue>3</issue>
<fpage>126</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">19764688</pub-id></element-citation></ref><ref id="b5-ARYA-09-363"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Miura</surname><given-names>K</given-names></name><name><surname>Turin</surname><given-names>TC</given-names></name><name><surname>Hozawa</surname><given-names>A</given-names></name><name><surname>Okuda</surname><given-names>N</given-names></name><name><surname>Okamura</surname><given-names>T</given-names></name><etal/></person-group>
<article-title> Relationship of the polyunsaturated to saturated fatty acid ratio to cardiovascular risk factors and metabolic syndrome in Japanese: the INTERLIPID study.</article-title>
<source>J Atheroscler Thromb</source>
<year>2010</year>
<volume>17</volume>
<issue>8</issue>
<fpage>777</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">20351467</pub-id></element-citation></ref><ref id="b6-ARYA-09-363"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Volk</surname><given-names>MG</given-names></name></person-group>
<article-title> An examination of the evidence supporting the association of dietary cholesterol and saturated fats with serum cholesterol and development of coronary heart disease.</article-title>
<source>Altern Med Rev</source>
<year>2007</year>
<volume>12</volume>
<issue>3</issue>
<fpage>228</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="pmid">18072819</pub-id></element-citation></ref><ref id="b7-ARYA-09-363"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>AH</given-names></name><name><surname>Erkkila</surname><given-names>AT</given-names></name><name><surname>Lamarche</surname><given-names>B</given-names></name><name><surname>Schwab</surname><given-names>US</given-names></name><name><surname>Jalbert</surname><given-names>SM</given-names></name><name><surname>Ausman</surname><given-names>LM</given-names></name></person-group>
<article-title> Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein.</article-title>
<source>Atherosclerosis</source>
<year>2003</year>
<volume>171</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="pmid">14642411</pub-id></element-citation></ref><ref id="b8-ARYA-09-363"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sartika</surname><given-names>RA</given-names></name></person-group>
<article-title> Dietary trans fatty acids intake and its relation to dyslipidemia in a sample of adults in Depok city, West Java, Indonesia.</article-title>
<source>Malays J Nutr</source>
<year>2011</year>
<volume>17</volume>
<issue>3</issue>
<fpage>337</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">22655455</pub-id></element-citation></ref><ref id="b9-ARYA-09-363"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dorfman</surname><given-names>SE</given-names></name><name><surname>Laurent</surname><given-names>D</given-names></name><name><surname>Gounarides</surname><given-names>JS</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Mullarkey</surname><given-names>TL</given-names></name><name><surname>Rocheford</surname><given-names>EC</given-names></name><etal/></person-group>
<article-title> Metabolic implications of dietary trans-fatty acids.</article-title>
<source>Obesity (Silver Spring)</source>
<year>2009</year>
<volume>17</volume>
<issue>6</issue>
<fpage>1200</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">19584878</pub-id></element-citation></ref><ref id="b10-ARYA-09-363"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bahrami</surname><given-names>Gh</given-names></name><name><surname>Mirzaeei</surname><given-names>Sh</given-names></name></person-group>
<article-title> The Evaluation of Fatty Acids Profile in Available Hydrogenated Oils and Margarines in Iran.</article-title>
<source>Iranian Heart Journal</source>
<year>2003</year>
<volume>4</volume>
<issue>3</issue>
<fpage>59</fpage>
<lpage>67</lpage>
</element-citation></ref><ref id="b11-ARYA-09-363"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nishida</surname><given-names>C</given-names></name><name><surname>Uauy</surname><given-names>R</given-names></name></person-group>
<article-title> WHO Scientific Update on health consequences of trans fatty acids: introduction.</article-title>
<source>Eur J Clin Nutr</source>
<year>2009</year>
<volume>63</volume>
<issue>Suppl 2</issue>
<fpage>S1</fpage>
<lpage>S4</lpage>
<pub-id pub-id-type="pmid">19424215</pub-id></element-citation></ref><ref id="b12-ARYA-09-363"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klonoff</surname><given-names>DC</given-names></name></person-group>
<article-title> Replacements for trans fats-will there be an oil shortage?</article-title>
<source>J Diabetes Sci Technol</source>
<year>2007</year>
<volume>1</volume>
<issue>3</issue>
<fpage>415</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">19885099</pub-id></element-citation></ref><ref id="b13-ARYA-09-363"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tarrago-Trani</surname><given-names>MT</given-names></name><name><surname>Phillips</surname><given-names>KM</given-names></name><name><surname>Lemar</surname><given-names>LE</given-names></name><name><surname>Holden</surname><given-names>JM</given-names></name></person-group>
<article-title> New and existing oils and fats used in products with reduced trans-fatty acid content.</article-title>
<source>J Am Diet Assoc</source>
<year>2006</year>
<volume>106</volume>
<issue>6</issue>
<fpage>867</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">16720128</pub-id></element-citation></ref><ref id="b14-ARYA-09-363"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Prakash</surname><given-names>H</given-names></name></person-group>
<article-title> Association of dietary ghee intake with coronary heart disease and risk factor prevalence in rural males.</article-title>
<source>J Indian Med Assoc</source>
<year>1997</year>
<volume>95</volume>
<issue>3</issue>
<fpage>67</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">9212571</pub-id></element-citation></ref><ref id="b15-ARYA-09-363"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kumar</surname><given-names>MV</given-names></name><name><surname>Sambaiah</surname><given-names>K</given-names></name><name><surname>Lokesh</surname><given-names>BR</given-names></name></person-group>
<article-title> Effect of dietary ghee-the anhydrous milk fat, on blood and liver lipids in rats.</article-title>
<source>J Nutr Biochem</source>
<year>1999</year>
<volume>10</volume>
<issue>2</issue>
<fpage>96</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="pmid">15539276</pub-id></element-citation></ref><ref id="b16-ARYA-09-363"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghafoorunissa</surname><given-names>G</given-names></name></person-group>
<article-title> Role of trans fatty acids in health and challenges to their reduction in Indian foods.</article-title>
<source>Asia Pac J Clin Nutr</source>
<year>2008</year>
<volume>17</volume>
<issue>Suppl 1</issue>
<fpage>212</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">18296340</pub-id></element-citation></ref><ref id="b17-ARYA-09-363"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ahmadi Asl</surname><given-names>N</given-names></name><name><surname>Alipour</surname><given-names>MR</given-names></name><name><surname>Andalib</surname><given-names>S</given-names></name><name><surname>Ebraheimi</surname><given-names>H</given-names></name></person-group>
<article-title> Effect of Ghee Oil on Blood Fat Profile and Passive Avoidance Learning in Male Rats.</article-title>
<source>Med J Tabriz Univ Med Sci</source>
<year>2008</year>
<volume>35</volume>
<issue>3</issue>
<fpage>7</fpage>
<lpage>10</lpage>
</element-citation></ref><ref id="b18-ARYA-09-363"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soelaiman</surname><given-names>IN</given-names></name><name><surname>Merican</surname><given-names>Z</given-names></name><name><surname>Mohamed</surname><given-names>J</given-names></name><name><surname>Abdul Kadir</surname><given-names>KB</given-names></name></person-group>
<article-title> Serum lipids, lipid peroxidation and glutathione peroxidase activity in rats on long-term feeding with coconut oil or butterfat (ghee).</article-title>
<source>Asia Pacific J Clin Nutr</source>
<year>1996</year>
<volume>5</volume>
<issue>4</issue>
<fpage>244</fpage>
<lpage>8</lpage>
</element-citation></ref><ref id="b19-ARYA-09-363"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Singh</surname><given-names>RB</given-names></name><name><surname>Niaz</surname><given-names>MA</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Beegom</surname><given-names>R</given-names></name><name><surname>Rastogi</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>JP</given-names></name><etal/></person-group>
<article-title> Association of trans fatty acids (vegetable ghee) and clarified butter (Indian ghee) intake with higher risk of coronary artery disease in rural and urban populations with low fat consumption.</article-title>
<source>Int J Cardiol</source>
<year>1996</year>
<volume>56</volume>
<issue>3</issue>
<fpage>289</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">8910075</pub-id></element-citation></ref><ref id="b20-ARYA-09-363"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>AH</given-names></name><name><surname>Ausman</surname><given-names>LM</given-names></name><name><surname>Jalbert</surname><given-names>SM</given-names></name><name><surname>Schaefer</surname><given-names>EJ</given-names></name></person-group>
<article-title> Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels.</article-title>
<source>N Engl J Med</source>
<year>1999</year>
<volume>340</volume>
<issue>25</issue>
<fpage>1933</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">10379016</pub-id></element-citation></ref><ref id="b21-ARYA-09-363"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Warnick</surname><given-names>GR</given-names></name><name><surname>Benderson</surname><given-names>J</given-names></name><name><surname>Albers</surname><given-names>JJ</given-names></name></person-group>
<article-title> Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.</article-title>
<source>Clin Chem</source>
<year>1982</year>
<volume>28</volume>
<issue>6</issue>
<fpage>1379</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmid">7074948</pub-id></element-citation></ref><ref id="b22-ARYA-09-363"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>WT</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group>
<article-title> Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.</article-title>
<source>Clin Chem</source>
<year>1972</year>
<volume>18</volume>
<issue>6</issue>
<fpage>499</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="b23-ARYA-09-363"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hunter</surname><given-names>JE</given-names></name></person-group>
<article-title> Dietary trans fatty acids: review of recent human studies and food industry responses.</article-title>
<source>Lipids</source>
<year>2006</year>
<volume>41</volume>
<issue>11</issue>
<fpage>967</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">17263298</pub-id></element-citation></ref><ref id="b24-ARYA-09-363"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>IA</given-names></name><name><surname>Wanders</surname><given-names>AJ</given-names></name><name><surname>Katan</surname><given-names>MB</given-names></name></person-group>
<article-title> Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans--a quantitative review.</article-title>
<source>PLoS One</source>
<year>2010</year>
<volume>5</volume>
<issue>3</issue>
<fpage>e9434</fpage>
<pub-id pub-id-type="pmid">20209147</pub-id></element-citation></ref><ref id="b25-ARYA-09-363"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mauger</surname><given-names>JF</given-names></name><name><surname>Lichtenstein</surname><given-names>AH</given-names></name><name><surname>Ausman</surname><given-names>LM</given-names></name><name><surname>Jalbert</surname><given-names>SM</given-names></name><name><surname>Jauhiainen</surname><given-names>M</given-names></name><name><surname>Ehnholm</surname><given-names>C</given-names></name><etal/></person-group>
<article-title> Effect of different forms of dietary hydrogenated fats on LDL particle size.</article-title>
<source>Am J Clin Nutr</source>
<year>2003</year>
<volume>78</volume>
<issue>3</issue>
<fpage>370</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">12936917</pub-id></element-citation></ref><ref id="b26-ARYA-09-363"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matthan</surname><given-names>NR</given-names></name><name><surname>Welty</surname><given-names>FK</given-names></name><name><surname>Barrett</surname><given-names>PH</given-names></name><name><surname>Harausz</surname><given-names>C</given-names></name><name><surname>Dolnikowski</surname><given-names>GG</given-names></name><name><surname>Parks</surname><given-names>JS</given-names></name><etal/></person-group>
<article-title> Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.</article-title>
<source>Arterioscler Thromb Vasc Biol</source>
<year>2004</year>
<volume>24</volume>
<issue>6</issue>
<fpage>1092</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">15087307</pub-id></element-citation></ref><ref id="b27-ARYA-09-363"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kelley</surname><given-names>DS</given-names></name><name><surname>Nelson</surname><given-names>GJ</given-names></name><name><surname>Love</surname><given-names>JE</given-names></name><name><surname>Branch</surname><given-names>LB</given-names></name><name><surname>Taylor</surname><given-names>PC</given-names></name><name><surname>Schmidt</surname><given-names>PC</given-names></name><etal/></person-group>
<article-title> Dietary alpha-linolenic acid alters tissue fatty acid composition, but not blood lipids, lipoproteins or coagulation status in humans.</article-title>
<source>Lipids</source>
<year>1993</year>
<volume>28</volume>
<issue>6</issue>
<fpage>533</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">8102770</pub-id></element-citation></ref><ref id="b28-ARYA-09-363"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Amoudi</surname><given-names>NS</given-names></name><name><surname>Abu Araki</surname><given-names>HA</given-names></name></person-group>
<article-title> Evaluation of vegetable and fish oils diets for the amelioration of diabetes side effects.</article-title>
<source>J Diabetes Metab Disord</source>
<year>2013</year>
<volume>12</volume>
<issue>1</issue>
<fpage>13</fpage>
<pub-id pub-id-type="pmid">23497544</pub-id></element-citation></ref><ref id="b29-ARYA-09-363"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asgary</surname><given-names>S</given-names></name><name><surname>Nazari</surname><given-names>B</given-names></name><name><surname>Sarrafzadegan</surname><given-names>N</given-names></name><name><surname>Saberi</surname><given-names>S</given-names></name><name><surname>Azadbakht</surname><given-names>L</given-names></name><name><surname>Esmaillzadeh</surname><given-names>A</given-names></name></person-group>
<article-title> Fatty acid composition of commercially available Iranian edible oils.</article-title>
<source>J Res Med Sci</source>
<year>2009</year>
<volume>14</volume>
<issue>4</issue>
<fpage>211</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">21772886</pub-id></element-citation></ref><ref id="b30-ARYA-09-363"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Achaya</surname><given-names>KT</given-names></name></person-group>
<article-title> Fat status of Indians-a review.</article-title>
<source>J Sci Ind Res</source>
<year>1987</year>
<volume>46</volume>
<issue>3</issue>
<fpage>112</fpage>
<lpage>26</lpage>
</element-citation></ref><ref id="b31-ARYA-09-363"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Noseda</surname><given-names>G</given-names></name></person-group>
<article-title> Fats and oils (including omega3, omega6).</article-title>
<source>Ther Umsch</source>
<year>2005</year>
<volume>62</volume>
<issue>9</issue>
<fpage>625</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">16218499</pub-id></element-citation></ref><ref id="b32-ARYA-09-363"><label>32</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Abdollahi</surname><given-names>M</given-names></name><name><surname>Campos</surname><given-names>H</given-names></name><name><surname>Houshiarrad</surname><given-names>A</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group>
<article-title> Consumption of trans fats and estimated effects on coronary heart disease in Iran.</article-title>
<source>Eur J Clin Nutr</source>
<year>2007</year>
<volume>61</volume>
<issue>8</issue>
<fpage>1004</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">17268422</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-ARYA-09-363" position="float"><label>Figure 1</label><caption><p>Flow chart showing number of eligible and excluded participants, number of participants allocated to intervention and control groups, and number of participants lost to post-text, as well as reasons for loss to follow-up</p></caption><graphic xlink:href="ARYA-09-363f1"/></fig><fig id="f2-ARYA-09-363" position="float"><label>Figure 2</label><caption><p>Comparison of the mean of serum lipid differences between unhydrogenated, ghee, soft margarine, blended, and hydrogenated oil groups
TG: Triglyceride; TC: Total cholesterol; HDL-C: High-density lipoprotein cholesterol;
LDL-C: Low-density lipoprotein cholesterol</p></caption><graphic xlink:href="ARYA-09-363f2"/></fig><fig id="f3-ARYA-09-363" position="float"><label>Figure 3</label><caption><p>Comparison of the mean of apolipoprotein differences between unhydrogenated, ghee, soft margarine, blended, and hydrogenated oil groups
APPOA: Apolipoprotein A; APPOB: Apolipoprotein B</p></caption><graphic xlink:href="ARYA-09-363f3"/></fig><table-wrap id="t1-ARYA-09-363" position="float"><label>Table 1</label><caption><p>Basic characteristics and serum lipids in the beginning of the study</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="5" colspan="1">Oil</th><th rowspan="1" colspan="1">Hydrogenated</th><th rowspan="1" colspan="1">Unhydrogenated</th><th rowspan="1" colspan="1">Ghee</th><th rowspan="1" colspan="1">Soft margarine</th><th rowspan="1" colspan="1">Blended</th><th rowspan="5" colspan="1">P</th></tr><tr><th colspan="5" rowspan="1">
<hr/>
</th></tr><tr><th rowspan="1" colspan="1">Mean &#x000b1; SD</th><th rowspan="1" colspan="1">Mean &#x000b1; SD</th><th rowspan="1" colspan="1">Mean &#x000b1; SD</th><th rowspan="1" colspan="1">Mean &#x000b1; SD</th><th rowspan="1" colspan="1">Mean &#x000b1; SD</th></tr><tr><th colspan="5" rowspan="1">
<hr/>
</th></tr><tr><th rowspan="1" colspan="1">n = 41</th><th rowspan="1" colspan="1">n = 43</th><th rowspan="1" colspan="1">n = 39</th><th rowspan="1" colspan="1">n = 41</th><th rowspan="1" colspan="1">n = 42</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (year)</td><td align="center" rowspan="1" colspan="1">32.8 &#x000b1; 11.1</td><td align="center" rowspan="1" colspan="1">33.9 &#x000b1; 11.6</td><td align="center" rowspan="1" colspan="1">35.4 &#x000b1; 10.9</td><td align="center" rowspan="1" colspan="1">36.5 &#x000b1; 12.2</td><td align="center" rowspan="1" colspan="1">36.6 &#x000b1; 11.6</td><td align="center" rowspan="1" colspan="1">0.203</td></tr><tr><td rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">26.5 &#x000b1; 4.4</td><td align="center" rowspan="1" colspan="1">26.1 &#x000b1; 5.3</td><td align="center" rowspan="1" colspan="1">25.7 &#x000b1; 4.6</td><td align="center" rowspan="1" colspan="1">26.4 &#x000b1; 4.13</td><td align="center" rowspan="1" colspan="1">26.8 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">0.821</td></tr><tr><td rowspan="1" colspan="1">Total cholesterol (mg/dl)</td><td align="center" rowspan="1" colspan="1">174.9 &#x000b1; 23.4</td><td align="center" rowspan="1" colspan="1">176.7 &#x000b1; 25.4</td><td align="center" rowspan="1" colspan="1">183.8 &#x000b1; 30.9</td><td align="center" rowspan="1" colspan="1">174.0 &#x000b1; 31.5</td><td align="center" rowspan="1" colspan="1">175.8 &#x000b1; 29.4</td><td align="center" rowspan="1" colspan="1">0.734</td></tr><tr><td rowspan="1" colspan="1">Triglyceride (mg/dl)</td><td align="center" rowspan="1" colspan="1">134.1 &#x000b1; 52.8</td><td align="center" rowspan="1" colspan="1">127.4 &#x000b1; 42.1</td><td align="center" rowspan="1" colspan="1">125.0 &#x000b1; 52.0</td><td align="center" rowspan="1" colspan="1">114. 9 &#x000b1; 33.7</td><td align="center" rowspan="1" colspan="1">109.5 &#x000b1; 26.1</td><td align="center" rowspan="1" colspan="1">0.268</td></tr><tr><td rowspan="1" colspan="1">HDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">43.3 &#x000b1; 7.5</td><td align="center" rowspan="1" colspan="1">45.3 &#x000b1; 6.9</td><td align="center" rowspan="1" colspan="1">44.0 &#x000b1; 5.6</td><td align="center" rowspan="1" colspan="1">45.3 &#x000b1; 6.7</td><td align="center" rowspan="1" colspan="1">47.2 &#x000b1; 6. 8</td><td align="center" rowspan="1" colspan="1">0.510</td></tr><tr><td rowspan="1" colspan="1">LDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">104.7 &#x000b1; 19.5</td><td align="center" rowspan="1" colspan="1">105.9 &#x000b1; 22.6</td><td align="center" rowspan="1" colspan="1">114.8 &#x000b1; 27.2</td><td align="center" rowspan="1" colspan="1">105.8 &#x000b1; 28.7</td><td align="center" rowspan="1" colspan="1">108.6 &#x000b1; 23.8</td><td align="center" rowspan="1" colspan="1">0.392</td></tr><tr><td rowspan="1" colspan="1">Apolipoprotein A (mg/dl)</td><td align="center" rowspan="1" colspan="1">129.9 &#x000b1; 17.3</td><td align="center" rowspan="1" colspan="1">126.5 &#x000b1; 17.4</td><td align="center" rowspan="1" colspan="1">122.0 &#x000b1; 14.0</td><td align="center" rowspan="1" colspan="1">111.1 &#x000b1; 150.0</td><td align="center" rowspan="1" colspan="1">123.4 &#x000b1; 12.9</td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td rowspan="1" colspan="1">Apolipoprotein B (mg/dl)</td><td align="center" rowspan="1" colspan="1">92.3 &#x000b1; 17.9</td><td align="center" rowspan="1" colspan="1">99.4 &#x000b1; 20.2</td><td align="center" rowspan="1" colspan="1">98.4 &#x000b1; 20.1</td><td align="center" rowspan="1" colspan="1">94.2 &#x000b1; 19.9</td><td align="center" rowspan="1" colspan="1">91.5 &#x000b1; 18.6</td><td align="center" rowspan="1" colspan="1">0.605</td></tr><tr><td rowspan="1" colspan="1">Gender (male) [n (%)]</td><td align="center" rowspan="1" colspan="1">17.0 &#x000b1; 41.5</td><td align="center" rowspan="1" colspan="1">18.0 &#x000b1; 41.9</td><td align="center" rowspan="1" colspan="1">16.0 &#x000b1; 41.0</td><td align="center" rowspan="1" colspan="1">19.0 &#x000b1; 46.0</td><td align="center" rowspan="1" colspan="1">18.0 &#x000b1; 42.9</td><td align="center" rowspan="1" colspan="1">0.677</td></tr><tr><td rowspan="1" colspan="1">Illiterate [n (%)]</td><td align="center" rowspan="1" colspan="1">17.0 &#x000b1; 41.4</td><td align="center" rowspan="1" colspan="1">15.0 &#x000b1; 34.9</td><td align="center" rowspan="1" colspan="1">14.0 &#x000b1; 35.9</td><td align="center" rowspan="1" colspan="1">16.0 &#x000b1; 39.0</td><td align="center" rowspan="1" colspan="1">16.0 &#x000b1; 38.2</td><td align="center" rowspan="1" colspan="1">0.042</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ARYA-09-363"><p>HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ARYA-09-363" position="float"><label>Table 2</label><caption><p>Comparison of serum lipid before and after the study</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="1">Oil</th><th rowspan="1" colspan="1">Before</th><th rowspan="1" colspan="1">After</th><th rowspan="3" colspan="1">P</th></tr><tr><th colspan="2" rowspan="1">
<hr/>
</th></tr><tr><th rowspan="1" colspan="1">Mean &#x000b1; SD</th><th rowspan="1" colspan="1">Mean &#x000b1; SD</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Hydrogenated</td><td colspan="3" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Total cholesterol (mg/dl)</td><td align="center" rowspan="1" colspan="1">174.9 &#x000b1; 23.4</td><td align="center" rowspan="1" colspan="1">178.6 &#x000b1; 25.3</td><td align="center" rowspan="1" colspan="1">0.039</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Triglyceride (mg/dl)</td><td align="center" rowspan="1" colspan="1">134.1 &#x000b1; 52.8</td><td align="center" rowspan="1" colspan="1">137.5 &#x000b1; 51.8</td><td align="center" rowspan="1" colspan="1">0.124</td></tr><tr><td rowspan="1" colspan="1">&#x02003;HDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">43.3 &#x000b1; 7.5</td><td align="center" rowspan="1" colspan="1">44.1 &#x000b1; 7.0</td><td align="center" rowspan="1" colspan="1">0.233</td></tr><tr><td rowspan="1" colspan="1">&#x02003;LDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">104.7 &#x000b1; 19.5</td><td align="center" rowspan="1" colspan="1">107.1 &#x000b1; 21.2</td><td align="center" rowspan="1" colspan="1">0.141</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein A (mg/dl)</td><td align="center" rowspan="1" colspan="1">129.9 &#x000b1; 17.3</td><td align="center" rowspan="1" colspan="1">125.8 &#x000b1; 13.3</td><td align="center" rowspan="1" colspan="1">0.031</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein B (mg/dl)</td><td align="center" rowspan="1" colspan="1">92.3 &#x000b1; 17.9</td><td align="center" rowspan="1" colspan="1">95.7 &#x000b1; 21.8</td><td align="center" rowspan="1" colspan="1">0.222</td></tr><tr><td rowspan="1" colspan="1">Unhydrogenated</td><td colspan="3" align="center" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Total cholesterol (mg/dl)</td><td align="center" rowspan="1" colspan="1">176.7 &#x000b1; 25.4</td><td align="center" rowspan="1" colspan="1">173.1 &#x000b1; 26.2</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Triglyceride (mg/dl)</td><td align="center" rowspan="1" colspan="1">127.4 &#x000b1; 42.1</td><td align="center" rowspan="1" colspan="1">122.8 &#x000b1; 41.6</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td rowspan="1" colspan="1">&#x02003;HDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">45.3 &#x000b1; 6.9</td><td align="center" rowspan="1" colspan="1">44.3 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">0.324</td></tr><tr><td rowspan="1" colspan="1">&#x02003;LDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">105.9 &#x000b1; 22.6</td><td align="center" rowspan="1" colspan="1">104.3 &#x000b1; 24.4</td><td align="center" rowspan="1" colspan="1">0.387</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein A (mg/dl)</td><td align="center" rowspan="1" colspan="1">126.5 &#x000b1; 17.4</td><td align="center" rowspan="1" colspan="1">127.8 &#x000b1; 14.8</td><td align="center" rowspan="1" colspan="1">0.352</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein B (mg/dl)</td><td align="center" rowspan="1" colspan="1">99.4 &#x000b1; 20.2</td><td align="center" rowspan="1" colspan="1">93.3 &#x000b1; 20.5</td><td align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td rowspan="1" colspan="1">Ghee</td><td colspan="3" align="center" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Total cholesterol (mg/dl)</td><td align="center" rowspan="1" colspan="1">183.8 &#x000b1; 30.9</td><td align="center" rowspan="1" colspan="1">183.5 &#x000b1; 28.6</td><td align="center" rowspan="1" colspan="1">0.703</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Triglyceride (mg/dl)</td><td align="center" rowspan="1" colspan="1">125.0 &#x000b1; 52.0</td><td align="center" rowspan="1" colspan="1">122.6 &#x000b1; 49.3</td><td align="center" rowspan="1" colspan="1">0.512</td></tr><tr><td rowspan="1" colspan="1">&#x02003;HDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">44.0 &#x000b1; 5.6</td><td align="center" rowspan="1" colspan="1">45.3 &#x000b1; 7.6</td><td align="center" rowspan="1" colspan="1">0.244</td></tr><tr><td rowspan="1" colspan="1">&#x02003;LDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">114.8 &#x000b1; 27.2</td><td align="center" rowspan="1" colspan="1">113.7 &#x000b1; 23.9</td><td align="center" rowspan="1" colspan="1">0.126</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein A (mg/dl)</td><td align="center" rowspan="1" colspan="1">122.0 &#x000b1; 14.0</td><td align="center" rowspan="1" colspan="1">125.4 &#x000b1; 13</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein B (mg/dl)</td><td align="center" rowspan="1" colspan="1">98.4 &#x000b1; 20.1</td><td align="center" rowspan="1" colspan="1">98.7 &#x000b1; 17.3</td><td align="center" rowspan="1" colspan="1">0.788</td></tr><tr><td rowspan="1" colspan="1">Blended</td><td colspan="3" align="center" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Total cholesterol (mg/dl)</td><td align="center" rowspan="1" colspan="1">175.8 &#x000b1; 29.4</td><td align="center" rowspan="1" colspan="1">173.5 &#x000b1; 27.6</td><td align="center" rowspan="1" colspan="1">0.225</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Triglyceride (mg/dl)</td><td align="center" rowspan="1" colspan="1">109.5 &#x000b1; 26.1</td><td align="center" rowspan="1" colspan="1">95.5 &#x000b1; 24.9</td><td align="center" rowspan="1" colspan="1">0.010</td></tr><tr><td rowspan="1" colspan="1">&#x02003;HDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">47.2 &#x000b1; 6. 8</td><td align="center" rowspan="1" colspan="1">47.4 &#x000b1; 7.3</td><td align="center" rowspan="1" colspan="1">0.438</td></tr><tr><td rowspan="1" colspan="1">&#x02003;LDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">108.6 &#x000b1; 23.8</td><td align="center" rowspan="1" colspan="1">107.1 &#x000b1; 23.5</td><td align="center" rowspan="1" colspan="1">0.451</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein A (mg/dl)</td><td align="center" rowspan="1" colspan="1">123.4 &#x000b1; 12.9</td><td align="center" rowspan="1" colspan="1">120 &#x000b1; 13.4</td><td align="center" rowspan="1" colspan="1">0.237</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein B (mg/dl)</td><td align="center" rowspan="1" colspan="1">91.5 &#x000b1; 18.6</td><td align="center" rowspan="1" colspan="1">92.5 &#x000b1; 15.4</td><td align="center" rowspan="1" colspan="1">0.507</td></tr><tr><td rowspan="1" colspan="1">Soft margarine</td><td colspan="3" align="center" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Total cholesterol (mg/dl)</td><td align="center" rowspan="1" colspan="1">174 &#x000b1; 31.5</td><td align="center" rowspan="1" colspan="1">169.4 &#x000b1; 25.6</td><td align="center" rowspan="1" colspan="1">0.128</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Triglyceride (mg/dl)</td><td align="center" rowspan="1" colspan="1">114.9 &#x000b1; 33.7</td><td align="center" rowspan="1" colspan="1">108.2 &#x000b1; 31.1</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td rowspan="1" colspan="1">&#x02003;HDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">45.3 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">46.0 &#x000b1; 6.0</td><td align="center" rowspan="1" colspan="1">0.345</td></tr><tr><td rowspan="1" colspan="1">&#x02003;LDL-C (mg/dl)</td><td align="center" rowspan="1" colspan="1">105.8 &#x000b1; 28.7</td><td align="center" rowspan="1" colspan="1">101.8 &#x000b1; 25.4</td><td align="center" rowspan="1" colspan="1">0.109</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein A (mg/dl)</td><td align="center" rowspan="1" colspan="1">111.1 &#x000b1; 14.6</td><td align="center" rowspan="1" colspan="1">115.8 &#x000b1; 21.2</td><td align="center" rowspan="1" colspan="1">0.099</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Apolipoprotein B (mg/dl)</td><td align="center" rowspan="1" colspan="1">94.2 &#x000b1; 20.0</td><td align="center" rowspan="1" colspan="1">94.1 &#x000b1; 22.4</td><td align="center" rowspan="1" colspan="1">0.723</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-ARYA-09-363"><p>HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-ARYA-09-363" position="float"><label>Table 3</label><caption><p>Comparison of the adjusted mean of serum lipids and changes in intervention groups vs reference group after the intervention</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="1">Group</th><th rowspan="1" colspan="1">Post-study</th><th colspan="2" rowspan="1">Change</th></tr><tr><th colspan="3" rowspan="1">
<hr/>
</th></tr><tr><th rowspan="1" colspan="1">Mean &#x000b1; SE</th><th rowspan="1" colspan="1">&#x003b2;<xref rid="tfn3-ARYA-09-363" ref-type="table-fn">*</xref></th><th rowspan="1" colspan="1">95% (CI)<xref rid="tfn4-ARYA-09-363" ref-type="table-fn">**</xref></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Total cholesterol (mg/dl)</td><td colspan="3" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Unhydrogenated</td><td align="center" rowspan="1" colspan="1">173.9 &#x000b1; 1.2</td><td align="center" rowspan="1" colspan="1">-7.1<sup><xref rid="tfn8-ARYA-09-363" ref-type="table-fn">c</xref></sup></td><td align="center" rowspan="1" colspan="1">-10.8-(-3.5)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Blended</td><td align="center" rowspan="1" colspan="1">175.2 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">-5.9<sup><xref rid="tfn7-ARYA-09-363" ref-type="table-fn">b</xref></sup></td><td align="center" rowspan="1" colspan="1">-10.1-(-1.7)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ghee</td><td align="center" rowspan="1" colspan="1">177.8 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">-3.3<sup><xref rid="tfn8-ARYA-09-363" ref-type="table-fn">c</xref></sup></td><td align="center" rowspan="1" colspan="1">-7.1-0.5</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Soft margarine</td><td align="center" rowspan="1" colspan="1">172.7 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">-8.4<sup><xref rid="tfn8-ARYA-09-363" ref-type="table-fn">c</xref></sup></td><td align="center" rowspan="1" colspan="1">-12.7-(-4.1)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hydrogenated</td><td align="center" rowspan="1" colspan="1">181.1 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">R<sup><xref rid="tfn5-ARYA-09-363" ref-type="table-fn">&#x02020;</xref></sup></td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">Triglyceride (mg/dl)</td><td colspan="3" align="center" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Unhydrogenated</td><td align="center" rowspan="1" colspan="1">117.7 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">-8.4<sup><xref rid="tfn8-ARYA-09-363" ref-type="table-fn">c</xref></sup></td><td align="center" rowspan="1" colspan="1">-12.6-(-4.1)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Blended</td><td align="center" rowspan="1" colspan="1">116.5 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">-9.6<sup><xref rid="tfn8-ARYA-09-363" ref-type="table-fn">c</xref></sup></td><td align="center" rowspan="1" colspan="1">-14.6-(-4.6)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ghee</td><td align="center" rowspan="1" colspan="1">119.8 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">-6.3<sup><xref rid="tfn7-ARYA-09-363" ref-type="table-fn">b</xref></sup></td><td align="center" rowspan="1" colspan="1">-10.7-(-2.0)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Soft margarine</td><td align="center" rowspan="1" colspan="1">114.8 &#x000b1; 1.9</td><td align="center" rowspan="1" colspan="1">-11.2<sup><xref rid="tfn8-ARYA-09-363" ref-type="table-fn">c</xref></sup></td><td align="center" rowspan="1" colspan="1">-16.2-(-6.3)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hydrogenated</td><td align="center" rowspan="1" colspan="1">126.1 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">LDL-Cholesterol (mg/dl)</td><td colspan="3" align="center" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Unhydrogenated</td><td align="center" rowspan="1" colspan="1">166.4 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">-3.8 (2.0)<sup><xref rid="tfn8-ARYA-09-363" ref-type="table-fn">c</xref></sup></td><td align="center" rowspan="1" colspan="1">-7.8-(-0.1)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Blended</td><td align="center" rowspan="1" colspan="1">106.7 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">-3.5 (2.3)</td><td align="center" rowspan="1" colspan="1">-8.1-1.1</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ghee</td><td align="center" rowspan="1" colspan="1">107.7 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">-2.5 (2.1)</td><td align="center" rowspan="1" colspan="1">-6.6-1.7</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Soft margarine</td><td align="center" rowspan="1" colspan="1">104.0 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">-2.5 (2.3)<sup><xref rid="tfn6-ARYA-09-363" ref-type="table-fn">a</xref></sup></td><td align="center" rowspan="1" colspan="1">-10.8-(-1.5)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hydrogenated</td><td align="center" rowspan="1" colspan="1">110.2 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">HDL-Cholesterol (mg/dl)</td><td colspan="3" align="center" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Unhydrogenated</td><td align="center" rowspan="1" colspan="1">43.6 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">-1.5 (0.9)</td><td align="center" rowspan="1" colspan="1">-3.2-0.1</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Blended</td><td align="center" rowspan="1" colspan="1">45.4 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">-0.07 (0.9)</td><td align="center" rowspan="1" colspan="1">-2-1.9</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ghee</td><td align="center" rowspan="1" colspan="1">46.1 &#x000b1; 0.6</td><td align="center" rowspan="1" colspan="1">0.6 (0.8)</td><td align="center" rowspan="1" colspan="1">-1.1-2.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Soft margarine</td><td align="center" rowspan="1" colspan="1">45.7 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">0.2 (1)</td><td align="center" rowspan="1" colspan="1">-1.7-2.2</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hydrogenated</td><td align="center" rowspan="1" colspan="1">45.5 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">Apolipoprotein A (mg/dl)</td><td colspan="3" align="center" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Unhydrogenated</td><td align="center" rowspan="1" colspan="1">126.3 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">3.7 (2.9)</td><td align="center" rowspan="1" colspan="1">-1.9-9.4</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Blended</td><td align="center" rowspan="1" colspan="1">120 &#x000b1; 2.4</td><td align="center" rowspan="1" colspan="1">-2.6 (3.3)</td><td align="center" rowspan="1" colspan="1">-9.1-4</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ghee</td><td align="center" rowspan="1" colspan="1">120.1 &#x000b1; 1.9</td><td align="center" rowspan="1" colspan="1">3.5 (2.9)<sup><xref rid="tfn8-ARYA-09-363" ref-type="table-fn">c</xref></sup></td><td align="center" rowspan="1" colspan="1">2.4-9.4</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Soft margarine</td><td align="center" rowspan="1" colspan="1">121.8 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">-0.8 (3.5)</td><td align="center" rowspan="1" colspan="1">-7.8-6.2</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hydrogenated</td><td align="center" rowspan="1" colspan="1">122.6 &#x000b1; 2.3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">Apolipoprotein B (mg/dl)</td><td colspan="3" align="center" rowspan="1">
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Unhydrogenated</td><td align="center" rowspan="1" colspan="1">90.5 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">-8.2 (2.3)<sup><xref rid="tfn7-ARYA-09-363" ref-type="table-fn">b</xref></sup></td><td align="center" rowspan="1" colspan="1">-13.2-(-3.2)</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Blended</td><td align="center" rowspan="1" colspan="1">96.2 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">-2.5 (2.9)</td><td align="center" rowspan="1" colspan="1">-8.2-3.3</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Ghee</td><td align="center" rowspan="1" colspan="1">96.7 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">-1.9 (2.6)</td><td align="center" rowspan="1" colspan="1">-7.1-3.2</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Soft margarine</td><td align="center" rowspan="1" colspan="1">95.5 &#x000b1; 2.2</td><td align="center" rowspan="1" colspan="1">-3.2 (2.9)</td><td align="center" rowspan="1" colspan="1">-8.9-2.7</td></tr><tr><td rowspan="1" colspan="1">&#x02003;Hydrogenated</td><td align="center" rowspan="1" colspan="1">98.6 &#x000b1; 2.0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-ARYA-09-363"><label>*</label><p>&#x000df;: Regression coefficient of baseline serum lipids</p></fn><fn id="tfn4-ARYA-09-363"><label>**</label><p>95% confidence interval</p></fn><fn id="tfn5-ARYA-09-363"><label>&#x02020;</label><p>Hydrogenated was considered as reference group</p></fn><fn id="tfn6-ARYA-09-363"><label>a</label><p>P &#x0003c; 0.05</p></fn><fn id="tfn7-ARYA-09-363"><label>b</label><p>P &#x0003c; 0.01</p></fn><fn id="tfn8-ARYA-09-363"><label>c</label><p>P &#x0003c; 0.001</p></fn><fn id="tfn9-ARYA-09-363"><p>SE: Standard Error; CI: Confidence interval; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol</p></fn></table-wrap-foot></table-wrap></floats-group></article>